Richard Daniell
Evp, Europe Commercial at Teva Pharmaceutical Industries Ltd (TEVA); Exec. Vp, European Commercial at Teva Pharmaceutical Industries Ltd (TEVA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| May 7SEC | TEVATeva Pharmaceutical Industries Ltd | Sell | 30,00055,755 held (−35%) | $35.40 | $1.1M | +16.1% |
| Mar 9SEC | TEVATeva Pharmaceutical Industries Ltd | Sell Plan | 17,29585,755 held (−17%) | $31.67 | $548K | +29.8% |
| Mar 6SEC | TEVATeva Pharmaceutical Industries Ltd | Sell Plan | 33,512123,127 held (−21%) | $32.46 | $1.1M | +26.6% |
| Mar 6SEC | TEVATeva Pharmaceutical Industries Ltd | Sell Plan | 20,461123,127 held (−14%) | $32.46 | $664K | +26.6% |
| Mar 6SEC | TEVATeva Pharmaceutical Industries Ltd | Sell Plan | 37,37285,755 held (−30%) | $32.95 | $1.2M | +24.7% |
| Mar 5SEC | TEVATeva Pharmaceutical Industries Ltd | Sell Plan | 62,25048,384 held (−56%) | $32.36 | $2.0M | +27.0% |
| Mar 5SEC | TEVATeva Pharmaceutical Industries Ltd | Sell Plan | 66,735123,127 held (−35%) | $32.36 | $2.2M | +27.0% |
| Dec 11SEC | TEVATeva Pharmaceutical Industries Ltd | Sell | 115,46848,384 held (−70%) | $28.68 | $3.3M | +43.3% |
- Sell
Evp, Europe Commercial Richard Daniell sold $1.1M of TEVA at $35.40 — cuts the stake by 35%.
- Sell
Evp, Europe Commercial Richard Daniell sold $548K of TEVA at $31.67 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Europe Commercial Richard Daniell sold $1.1M of TEVA at $32.46 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Europe Commercial Richard Daniell sold $664K of TEVA at $32.46 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Europe Commercial Richard Daniell sold $1.2M of TEVA at $32.95 — cuts the stake by 30%; pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Europe Commercial Richard Daniell sold $2.0M of TEVA at $32.36 — cuts the stake by 56%; pre-scheduled 10b5-1 plan sale.